As transcription factors have been found to play an increasingly important regulatory role in the development and expansion of adipose tissue, many transcription factors such as C/EBPα, C/EBPβ, and PPARγ have been regarded as potential targets for obesity-related metabolic diseases [16,35]. This evidence concerns the gene CEBPB and metabolic disease.